Transcriptional activation of interferon ␤ (IFN-␤), an antiviral cytokine, requires the assembly of IRF-3 and CBP/p300 at the promoter region of the IFN-␤ gene. The crystal structure of IRF-3 in complex with CBP reveals that CBP interacts with a hydrophobic surface on IRF-3, which in latent IRF-3 is covered by its autoinhibitory elements. This structural organization suggests that virus-induced phosphoactivation of IRF-3 triggers unfolding of the autoinhibitory elements and exposes the same hydrophobic surface for CBP interaction. The structure also reveals that the interacting CBP segment can exist in drastically different conformations, depending on the identity of the associating transcription cofactor. The finding suggests a possible regulatory mechanism in CBP/p300, by which the interacting transcription factor can specify the coactivator's conformation and influence the transcriptional outcome.
Introduction

A key event in mounting the mammalian innate immune response upon virus infection is the transcriptional activation of the antiviral cytokine, interferon β (IFN-
Here, we report the crystal structure of a complex between the IBiD of CBP and the IAD of IRF-3 at 2.4 Å resolution. The structure reveals that the IBiD binds to a hydrophobic surface on IAD, which in latent IRF-3 is buried by the autoinhibitory elements. The structure further reveals a novel, to our knowledge, conformation of the IBiD that is markedly different from that of the free IBiD or the IBiD in the ACTR/IBiD complex. The result suggests a possible regulatory mechanism in CBP/p300, by which binding of a transcriptional comodulator at the IBiD can stabilize CBP/p300 in one of its multiple conformations to influence the transcriptional outcome. (Table 1 ). The two copies are related by a 2-fold axis, and they have essentially the same structure with a root mean square deviation of 0.1 Å, when superimposed over all atoms. Only one complex is described here since there is no evidence that the interactions between the two copies are physiologically relevant. Analytical ultracentrifugation analysis shows that the exact IRF-3/IBiD complex used in the structural study does not oligomerize in solution ( Figure 1A 
Results
Overall
The IRF-3/IBiD Interface
The association between IRF-3 and the IBiD covers a hydrophobic interface of approximately 1800 Å 2 . The interacting hydrophobic residues of IRF-3 involve primarily Ile326, Leu329, and Ile330 in the H3 helix, as well as Cys371, Leu372, Leu375, Met378, and Val381 in the H4 helix ( Figure 1D, right) . In addition, Trp202 on the β1 strand also contributes to the buried hydrophobic interface. The interacting hydrophobic residues of the IBiD are distributed over three helices, involving primarily Leu2071 and Leu2075 in the H1 helix; Val2087, Ile2090, and Leu2091in the H2 helix; as well as Leu2097 and Phe2101 in the H3 helix ( Figure 1D, left) . In addition to these core hydrophobic contacts, the complex is also stabilized by a limited set of H bond interactions on the outskirts of the interface ( Figure 1D H3A and H4A mutants contained mutations of the hydrophobic residues in the H3 and H4 helices, respectively, of IRF-3 and were designed to disrupt the hydrophobic interaction with CBP. The SA and EA mutants of IRF-3 were designed to disrupt the polar contacts with CBP, whereas the SA mutant had Ser221 mutated to alanine, and the EA mutant had both Glu201 and Glu203 mutated to alanine. While Myc-tagged, wild-type IRF-3 exhibited some interaction with CBP, There is a remarkable similarity between the interface of the IRF-3/IBiD complex and the interface buried by the autoinhibitory elements in latent IRF-3. This results from a similar spatial display of the interacting side chains in the IBiD and the IRF-3 autoinhibitory elements, despite their distinct secondary structural arrangements ( Figure 1D, left) . Specifically, T2074 in the H1 helix of the IBiD occupies the same space as N389 in the autoinhibitory structure; Q2083, V2087, I2090, L2091, and N2094 in the H2 helix of the IBiD occupy the same space as H394, L393, L195, L192, and L415, respectively, in the autoinhibitory structure; L2097 and F2101 in the H3 helix of the IBiD occupy the same space as L412 and Y408, respectively, in the autoinhibitory structure. In addition to the above-mentioned pairs of matching residues, L2071 in the IBiD and V391 in the autoinhibitory structure occupy a distinct, nonoverlapping space, suggesting that a minor structural rearrangement on the complementary interface of IRF-3 is required in the transition from the autoinhibited to the IBiD bound state. Indeed, the side chain of M378 in the H4 helix of IRF-3 needs to undergo a rotameric rearrangement to form a complex with the IBiD ( Figure  1D, right) .
Complex Formation Requires Conformational Changes in IRF-3
The mutually exclusive nature of the IRF-3 autoinhibitory conformation and the IRF-3/IBiD interaction suggests that the autoinhibitory structures of IRF-3 need to be displaced upon activation. Upon virus infection, the IKK-related kinases, IKK⑀ and/or TBK1, activate latent IRF-3 through phosphorylation of defined Ser/Thr residues within the C-terminal autoinhibitory elements (Fitzgerald et al., 2003; Sharma et al., 2003) . The crystal structure of latent IRF-3 revealed that these phosphorylation sites are partially buried in a hydrophobic environment ( Figure 1C) (Qin et al., 2003) . A plausible activation mechanism, consistent with the structures, is that the repulsive force between the phosphorylated residues and their hydrophobic environment leads to unfolding of the autoinhibitory elements and consequent exposure of the H3 and H4 helices for interaction with the IBiD. The autoinhibitory elements of IRF-3 are not observed in the IRF-3/IBiD complex, due to exclusion of the C-terminal autoinhibitory elements in the expression construct, and the structural disordering of the N-terminal autoinhibitory element.
The L5 loop of IRF-3 in complex with the IBiD assumes a different structural arrangement when compared to that in the autoinhibited IRF-3 (compare Figures 1B and 1C) . Although a definitive function of the L5 loop has not been assigned, mutation of the basic residues K360 and R361 within the loop disables the virus-induced IRF-3 oligomerization and transcriptional activation, suggesting that the L5 loop is important for activation (Qin et al., 2003). It is not obvious whether the observed structural change of the L5 loop has functional implication since the L5 loop also forms part of the crystal packing contacts in the IRF-3/IBiD complex.
Complex Formation Requires Conformational Changes in the IBiD
The structure of the uncomplexed IBiD has been investigated by NMR. In one study, the free IBiD forms a small globular domain with three interacting helices (Lin et al., 2001a). However, another study suggested that the free IBiD contains a helical secondary structure, but no fixed tertiary structure, characteristic of a molten globule (Demarest et al., 2004) . Thus, the reported structure of the free IBiD, which is used for comparison here, may represent the more stable form among the many possible conformations that can exist in solution.
The IBiD in the IRF-3/IBiD complex has a different conformation when compared to the uncomplexed IBiD structure (Figure 3) . The H2 helix in the IRF-3/IBiD complex is longer, as a consequence of a disorder-to-order transition of a glutamine-rich segment from residue 2079 to residue 2085 upon complex formation. The ordering of this region correlates with its direct contact with IRF-3. There is also a significant change in the relative positions of the H1 and H2 helices. When viewed through the plane formed by the H2 and H3 helices, the H1 helix in the IRF-3/IBiD complex points toward the opposite side of the plane as compared to that in the uncomplexed structure (Figure 3, right) . These structural rearrangements of the IBiD make available a cluster of the above-mentioned hydrophobic side chains that are important for interaction with IRF-3 but are otherwise buried in an intramolecular hydrophobic core in the uncomplexed structure.
Two Distinct Conformations of the IBiD Induced by Different Transcriptional Partners
As mentioned, the IBiD can interact with diverse transcriptional partners with no apparent sequence or structural homology. In addition to the IRF-3/IBiD complex structure described here, an NMR structure of a (Figure 4) . There is a marked difference in the relative position of the N and C termini between the two drastically different conformations of the IBiD. Since the IBiD is an internal segment of CBP, these observations suggest that the differences in the IBiD structures, depending upon the interaction transcriptional partner, may propagate into global differences in CBP/p300 structures in the two different complexes.
Despite the distinct mode of contacts in the two IBiD complexes, the same set of hydrophobic residues mentioned above is used by the IBiD for interaction. Three factors appear to facilitate the adaptability of the IBiD in macromolecular recognition. First, the flexibility of the L1 loop in the IBiD allows the H1 helices in the two different complexes to swing in different directions, pivoting about the flexible L1 loop, while keeping the relative angle between the H2 and H3 helices largely unchanged. Second, the polyglutamine sequences of the IBiD in the two complexes can be induced to form different structures upon complex formation. In the IRF-3/ IBiD complex, the polyglutamine sequence forms an extended H2 helix (Figure 4, left) , and most of the glutamine side chains participate in van der Waals contacts The structure demonstrates that these autoinhibitory elements have to be displaced during activation to allow CBP to interact with IRF-3, presumably through virus-induced phosphorylation and unfolding of the C-terminal segment. The structure also reveals that oligomerization of IRF-3 is not required for CBP interaction, since both the crystal structure and analytical ultracentrifugation reveal a 1:1 complex between IRF-3 and CBP. It should be noted that this finding does not contradict the current paradigm of IRF-3 activation, in which virus-induced phosphorylation of IRF-3 leads to its dimerization, nuclear translocation, and interaction with CBP/p300. Rather, the result suggests that a distinct structural domain not present in the crystal structure, probably the C-terminal tail, is responsible for oligomerization. Consistent with this notion, a phosphomimetic form of IRF-3, IRF-3(S396/398D), in which both Ser396 and Ser398 phosphorylation sites within the C-terminal tail were mutated to aspartic acids, forms a complex with the IBiD, and this complex has a strong propensity to oligomerize (data not shown). This difference with the behavior of unphosphorylated IRF-3, merely due to pseudophosphorylation of the two serines, indicates that the phosphorylated C-terminal sequence of IRF-3 plays a primary role in IRF-3 oligomerization, potentially by bridging subunit-subunit contacts. Although the structure of the active, oligomeric state of IRF-3 in complex with CBP remains to be elucidated, further conformational changes of the IBiD in the oligomeric form of IRF-3 are not anticipated, as the structure is supported by mutational analysis in the virus infection assay, which represents the interaction of activated wild-type IRF-3 with CBP.
This work also reveals the unique features on IRF-3 that are responsible for its interaction with CBP/p300. The interactions are mediated by hydrophobic contacts via the H3 and H4 helices as well as hydrophilic contacts through Glu203 and Ser221. These interacting residues on IRF-3 are only partially conserved in other IRF family members, suggesting that other IRFs employ alternative structural strategies for interaction or do not interact with CBP/p300. For example, it was demonstrated that the interaction between IRF-7 and CBP/ p300 requires multiple regions of the CBP/p300 (Yang  et al., 2003) . Consistently, Glu203 and Ser221 as well as a subset of the hydrophobic residues on the H3 and H4 helices of IRF-3 are not conserved in IRF-7, making it unlikely for the IBiD alone to interact with IRF-7. In this regard, it is interesting to speculate that there may be significant differences in the way CBP/p300 interacts with the homodimeric IRF-3 versus the hetero- Allosteric control of coactivator function may be a general mechanism for regulating transcription. It has been observed, by using electron microscopy and three-dimensional reconstruction, that the multisubunit coactivator complex CRSP assumes different conformations upon binding different transcription factors (Taatjes et al., 2002 (Taatjes et al., , 2004 . Each transcription factor interacts with a distinct subunit of the CRSP complex to induce a subunit conformational change that propagates to the entire coactivator molecule. In comparison, CBP/p300 undergoes activator-dependent conformational changes via a single site, the IBiD, which forms different structures upon binding different activators. Despite the different mechanisms, an activator-induced conformational change of coactivators is likely to play a key role in transcriptional regulation. A coactivator's conformation may define the repertoire of transcription factors that it binds and hence the genes that it regulates. A conformational change may also control the coactivator's enzymatic function and/or its communication with the polymerase. Further studies will be necessary to address these possibilities.
In conclusion, the studies described here reveal the structural basis of IRF-3 interaction with the transcriptional coactivator CBP/p300 and shed light on the mechanism of IRF-3 activation. The observation that the IBiD of CBP/p300 can assume drastically distinct conformations depending on the identity of the interacting transcriptional partner implies an allosteric model in CBP/p300 function, where binding of a comodulator to CBP/p300 may influence the overall conformation of CBP/ p300 and its function in transcription. This mechanism provides another level of regulation in the control of gene expression.
Experimental Procedures
Protein Expression, Purification, and Crystallization The sequences encoding the IAD of IRF-3 (residues 173-394) and the IBiD of CBP (residues 2067-2112) were subcloned into pGEX-6P-1 and pET-28a, respectively, and coexpressed in E. coli. The complex was extracted by glutathione Sepharose and released by PreScission Protease to remove the GST moiety (Amersham). The complex was further purified on a DEAE column equilibrated with 20 mM Tris (pH 7.4), 10 mM NaCl, 0.1 mM EDTA, and 1 mM DTT and was eluted by a NaCl gradient from 10 mM to 300 mM. The purified complex was concentrated to 12 mg/ml. Crystals were obtained by the hanging drop vapor diffusion technique with well solution containing 0.2 M ammonium acetate, 0.15 M Mg acetate, 5% (v/v) PEG 4000, and 50 mM Na HEPES (pH 7.0). Figure 1A) . Thus, the IRF-3/CBP complex is a monomer under these conditions and over this concentration range. For transcription reporter assays, HeLa cells were transiently transfected with the P31x3 reporter plasmid and β-galactosidase expression plasmid, as well as the IRF-3 expression plasmid(s), as indicated ( Figure 2C ). All transfected DNA amounts were kept constant by adding empty expression vector as needed. Infection with Sendai virus (100 HA units/ml) was done at 24 hr after transfection for 20 hr. Luciferase assays were carried out and normalized as described (Qin et al., 2003) .
Structure Determination
Immunoprecipitation and Western Blot Analysis
Supplemental Data
Supplemental data including the complete analytical ultracentrifugation analysis are available at http://www.structure.org/cgi/content/ full/13/9/1269/DC1/.
